About: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 August 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в серпні 2006 (uk) scientific article published on 14 August 2006 (en) artículu científicu espublizáu n'agostu de 2006 (ast)
publication date	wds:Q80111732-67C43741-2195-4DCA-84D3-DDFFE1AE1063
publication date	2006-08-14 00:00:00Z (xsd:dateTime)
author name string	wds:Q80111732-14B50112-3E8A-4FC4-AC3C-72D85F69ABC4 wds:Q80111732-191A2B22-DE06-4ABB-8D4F-A0B3BC827553 wds:Q80111732-1A3B92F5-9B55-46E0-B666-10E9A2CF6B3A wds:Q80111732-23EBA81B-E33F-4A21-8CCF-CE6D51865D4A wds:Q80111732-289434F8-C563-462E-AD90-45B42C115508 wds:Q80111732-2B8204CF-5FCD-446F-B154-458DD848B87D wds:Q80111732-3CF1AA73-C07B-4A46-B1CB-7D3EE291F8D8 wds:Q80111732-6FA6A89E-5845-4F40-8E51-587BF5FF29EA wds:Q80111732-704DF88F-BDB1-4843-8FB1-2A90B105D007 wds:Q80111732-795014BB-380F-4214-8DC1-BB041ADDC640 wds:Q80111732-7C772907-503C-412B-AE0B-C4D725DECDBC wds:Q80111732-AF26BB1A-EAA3-4C54-BDE8-3EAE639A20A6 wds:Q80111732-B68C953D-EFBE-4C6B-9CD8-0257C860F549 wds:Q80111732-B6C0072D-C8C7-41E4-AA19-AF9F64C5EB11 wds:Q80111732-CDB49CE4-F28E-4883-B439-EA7B47F1524A wds:Q80111732-EC3CBC6B-A57A-4854-8942-7125B3729BC6 wds:Q80111732-F8BAA3B0-C097-4337-BAEC-D4099828D010
author name string	Thomas Crawford Hakan Oral Fred Morady Krit Jongnarangsin Aman Chugh Frank Bogun Eric Good Frank Pelosi Mehmet Ozaydin Darryl Elmouchi David Tschopp Petar Igic Scott Reich Alan Wimmer Sujoya Dey Jackie Fortino Sundar Sankaran
rdfs:label	Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (en) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (nl)
skos:prefLabel	Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (en) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (nl)
name	Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (en) Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (nl)
title	wds:Q80111732-CE67466F-ECE7-4E0E-8B20-B0A823110C97
title	Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation (en)
page(s)	wds:Q80111732-290C25B3-B6B7-4654-87C8-6BB2E7242E6D
page(s)	759-765
instance of	wds:Q80111732-0CE49515-24AD-4969-A464-C762ADF11107
instance of	scholarly article
main subject	wds:Q80111732-B1C8DDFF-8AD2-4495-9C00-C78606F1646B
main subject	atrial fibrillation
PubMed ID	wds:Q80111732-003314D3-4028-4F9A-B1D5-A9BC244CCF31
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16908760
PubMed ID	16908760
published in	wds:Q80111732-FDDDF0BE-B7E6-46DF-8288-2D8BCE3C0A12
published in	Circulation
issue	wds:Q80111732-90B2B057-FC0A-41B6-9702-B4591C6956B6
volume	wds:Q80111732-553E9072-4BBE-46EB-A66D-927AA4A269C5
issue	8
volume	114
DOI	wds:Q80111732-6F09970E-7C55-4741-96F2-847DE1A66E56
DOI	http://dx.doi.org/10.1161/CIRCULATIONAHA.106.641225
DOI	10.1161/CIRCULATIONAHA.106.641225
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80111732
is cites work of	2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Bilateral occipital lobe infarction with altitudinal field loss following radiofrequency cardiac catheter ablation Femoral vascular complications following catheter ablation of atrial fibrillation Effectiveness of a strategy to reduce major vascular complications from catheter ablation of atrial fibrillation. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation Catheter ablation for atrial fibrillation Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation Anticoagulation after Atrial Fibrillation Ablation: Many Blanks to Fill Late thromboembolic events after circumferential pulmonary vein ablation of atrial fibrillation European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Catheter ablation of atrial fibrillation to reduce stroke risk Atrial Fibrillation Ablation: First-Line Therapy? Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry The impact of CHADS2 score on late stroke after the Cox maze procedure Use of the CHA2DS2VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience Femoral vein thrombosis after right-sided electrophysiological procedures Atrial fibrillation ablation complications [Nightmares in atrial fibrillation ablation--identification, management, and prevention of complications in radiofrequency ablation of atrial fibrillation] Efficacy and safety of radiofrequency catheter ablation in the elderly

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software